AWH 0.99 (-33.56%)
US04537Y1091Medical Diagnostics & ResearchDiagnostics & Research

Aspira Womens Health (AWH) Competitor Comparison

We are evaluating the key criteria listed to compare Aspira Womens Health (AWH) against its competitors in the Diagnostics & Research industry.

Earnings per Share - AWH ranking 41 / 57

These are the competitors of Aspira Womens Health in the industry Diagnostics & Research ranked by earnings per share
1. Mettler-Toledo MTD
35.73
2. Thermo Fisher Scientific TMO
15.59
3. IDEXX Laboratories IDXX
10.32
4. Waters WAT
10.17
5. Medpace Holdings MEDP
9.81
6. Charles River Laboratories CRL
8.5
7. Icon ICLR
8.24
8. Quest Diagnostics DGX
7.43
9. IQVIA Holdings IQV
7.32
10. Lantheus Holdings LNTH
6.56
11. Danaher DHR
5.44
12. Laboratory Corp of America Holdings LH
4.67
13. Trinity Biotech TRIB
4.25
14. Agilent Technologies A
4.22
15. PerkinElmer PKI
2.78
16. DexCom DXCM
1.53
17. Qiagen QGEN
1.52
18. National Research NRC
1.24
19. Syneos Health SYNH
0.7
20. Global Cord Blood CO
0.59
21. RadNet RDNT
0.37
22. Interpace Biosciences IDXG
0.28
23. Sotera Health SHC
0.19
24. Neogen NEOG
0.02
25. Ortho Clinical Diagnostics Holdings OCDX
0
26. Olink Holding OLK
-0.27
27. Bioventus BVS
-0.33
28. Enzo Biochem ENZ
-0.35
29. MaxCyte MXCT
-0.35
30. Anixa Biosciences ANIX
-0.37
31. Biodesix BDSX
-0.54
32. NeoGenomics NEO
-0.66
33. Psychemedics PMD
-0.77
34. bioAffinity Technologies BIAF
-0.93
35. Neuronetics STIM
-0.94
36. Sera Prognostics SERA
-1.07
37. Exagen XGN
-1.09
38. Pacific Biosciences of California PACB
-1.14
39. Co-Diagnostics CODX
-1.31
40. Exact Sciences EXAS
-1.31
41. Aspira Womens Health AWH
-1.41
42. MDxHealth MDXH
-1.44
43. DarioHealth DRIO
-1.68
44. Personalis PSNL
-1.9
45. Heska HSKA
-1.92
46. Organovo Holdings ONVO
-2.16
47. Inotiv NOTV
-2.77
48. Myriad Genetics MYGN
-2.8
49. Natera NTRA
-3.11
50. Twist Bioscience TWST
-3.36
51. Precipio PRPO
-3.36
52. CareDx CDNA
-3.42
53. Guardant Health GH
-3.92
54. Prenetics Global PRE
-4.28
55. Fulgent Genetics FLGT
-5.56
56. Illumina ILMN
-8.15
57. SeqLL SQL
-16.4

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.